Cara Therapeutics Announces Presentation at the 22nd Annual Needham Virtual Healthcare Conference
STAMFORD, Conn., April 10, 2023 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc. (Nasdaq: CARA), a commercial-stage biopharmaceutical…
Year: 2023
Cara Therapeutics Announces Presentation at the 22nd Annual Needham Virtual Healthcare Conference
STAMFORD, Conn., April 10, 2023 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc. (Nasdaq: CARA), a commercial-stage biopharmaceutical…
TScan Therapeutics Announces Appointment of Barbara Klencke, M.D., to its Board of Directors
Barbara Klencke, M.D. Dr. Klencke is an accomplished oncology drug developer with a demonstrated track…
Verizon continues to upgrade St. Louis’ best network
Recent upgrades lead to testing results that show Verizon customers have the best network experience…
DT Research to Unveil Medical Graphics Stations Purpose-built for Augmented Reality Navigation, Robotic Surgeries and 3D Simulations at HIMSS
All-in-one computers powered by NVidia® graphics cards and Intel® high-performance processors designed to provide real-time…
FloQast Introduces Custom Value Assessment Report for Improved Efficiency Across Financial Close Processes
Custom value assessment calculator quantifies accounting transparency and agility for teams seeking optimization and modernization…
FourKites and Pegasus Logistics Group Partner to Provide End-to-End Multimodal Visibility to Customers Worldwide
Adoption of FourKites’ leading supply chain visibility platform signals Pegasus Logistics’ long-term commitment to digitization…
Orezone Intersects 30.86 g/t Au Over 5.00m in Ongoing Oxide Exploration
Figure 1 Bomboré Plan Map Overview VANCOUVER, British Columbia, April 10, 2023 (GLOBE NEWSWIRE) —…
DOCOMO Grants Standard Essential Patent License to Samsung
TOKYO, Apr 10, 2023 – (JCN Newswire) – NTT DOCOMO, INC. announced today that it…
Concerned Shareholders of Cano Health Issue Open Letter Regarding the Urgent Need for Leadership and Strategy Changes at the Company
Group Owning ~36% of Company Outlines Serious Concerns Pertaining to CEO Conduct, Capital Allocation and…
SolarWinds Earns Prestigious 5-Star Rating in 2023 CRN Partner Program Guide
Transform Partner Program recognized for offering partners significant growth opportunities, profit potential, and world-class tools…
Consensus Cloud Solutions to Host Q1 Investor Call on May 9, 2023
LOS ANGELES–(BUSINESS WIRE)–Consensus Cloud Solutions, Inc., (NASDAQ: CCSI), invites the public, members of the press,…
Ault Alliance Announces Special Dividend with a Record Date of April 20, 2023
LAS VEGAS–(BUSINESS WIRE)–$AP #140_million_shares_distributed—Ault Alliance, Inc. (NYSE American: AULT), a diversified holding company, (“Ault Alliance”…
Mainz Biomed Provides Full Year 2022 Financial Results
ColoAlert Revenue Increases 130% Year over Year Year End Cash Balance of $17.1 Million BERKELEY,…
Get Lifetime Access to Aura Skypool in Dubai With Rare FND
DUBAI, UAE, Apr 10, 2023 – (ACN Newswire) – Rare FND, a revolutionary crowdsourcing platform…
Chinese Spirits Maker Jiangxiaobai Applies Its ESG Philosophy across the Whole of the Industry Chain
Chongqing, CHINA, Apr 10, 2023 – (ACN Newswire) – Chongqing Jiangxiaobai Liquor Co., Ltd. (“Jiangxiaobai”),…
HotelRunner Introduces ‘Elite’: An Exclusive Path to Efficiency and Profitability
LONDON, Apr 10, 2023 – (ACN Newswire) – HotelRunner, the leading hospitality and travel technologies…
FiscalNote to Participate in Fireside Chat at The SHARE & NYSE Event
WASHINGTON–(BUSINESS WIRE)–FiscalNote Holdings, Inc. (NYSE: NOTE) (“FiscalNote”), a leading AI-driven enterprise SaaS technology provider of…
OBI Pharma Announces Poster Presentations at AACR 2023 Annual Meeting for OBI-999 combination synergy with checkpoint inhibitor as well as Globo H-targeted CAR T-cell immunotherapy
Poster Presentations to highlight the latest research on OBI-999’s (anti-Globo H ADC) synergistic anti-tumor effect…
Nuance Pharma Announces Dosing of First Patient in ENHANCE – China Phase 3 Trial for COPD
LONDON and RALEIGH, N.C., April 10, 2023 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA)…